Economic feasibility of the sugar beet-to-ethylene value chain.

ChemSusChem

Roland Berger Strategy Consultants, Strawinskylaan 581, 1077 XX Amsterdam (The Netherlands).

Published: September 2013

As part of a long-term strategy toward renewable feedstock, a feasibility study into options for the production of bioethylene by integrating the sugar beet-to-ethanol-to-ethylene value chain. Seven business cases were studied and tested for actual economic feasibility of alternative sugar-to-ethanol-to-ethylene routes in comparison to fossil-fuel alternatives. An elaborate model was developed to assess the relevant operational and financial aspects of each business case. The calculations indicate that bioethylene from sugar beet is not commercially viable under current market conditions. In light of expected global energy and feedstock prices it is also reasonable to expect that this will not change in the near future. To consider biorenewable sources as starting material, they need to be low in cost (compared to sugar beets) and also require less capital and energy-intensive methods for the conversion to chemicals. In general, European sugar prices will be too high for many chemical applications. Future efforts for in sugar-to-chemicals routes should, therefore, focus on integrated process routes and process intensification and/or on products that contain a significant part of the original carbohydrate backbone.

Download full-text PDF

Source
http://dx.doi.org/10.1002/cssc.201300478DOI Listing

Publication Analysis

Top Keywords

economic feasibility
8
sugar
5
feasibility sugar
4
sugar beet-to-ethylene
4
beet-to-ethylene chain
4
chain long-term
4
long-term strategy
4
strategy renewable
4
renewable feedstock
4
feedstock feasibility
4

Similar Publications

Microtiter-plate-based systems are unified platforms of high-throughput experimentation (HTE). These polymeric devices are used worldwide on a daily basis-mainly in the pharmaceutical industry-for parallel syntheses, reaction optimization, various preclinical studies and high-throughput screening methods. Accordingly, laboratory automation today aims to handle these commercially available multiwell plates, making developments focused on their modifications a priority area of modern applied research.

View Article and Find Full Text PDF

A vast sum of fish waste is being annually discarded by marine fishing industries imposing serious environmental pollution concerns. However, these aquatic discarded matters are captivating sources of collagen, a fibrous protein with eminent social and economic relevance. Collagen is conventionally recovered using outdated complex processes requiring many reagents, multiple steps, and extended periods.

View Article and Find Full Text PDF

Aerobic granules extraction inhibits overgrowth of filamentous bacteria during start-up of aerobic granular sludge.

Bioresour Technol

January 2025

School of Resources and Environment, Hubei Key Laboratory of Regional Development and Environmental Response, Hubei University, Wuhan 430062, China.

In aerobic granular sludge (AGS) system, N-acyl homoserine lactones (AHLs) can effectively regulate the community structure and control filamentous bulking. It would be economically feasible to make mature granules into AHLs-rich AGS extract (AE) to replace synthesized AHLs. In this study, two SBRs were run in a fully aerobic environment and a short cycle (4 h) to culture AGS: R1 with AE adding; R2 served as control.

View Article and Find Full Text PDF

From Vision to Reality: The EU's Pharmaceutical Reforms and the Path to Improved Access.

Pharmacoecon Open

January 2025

Department of Health Policy and Medical Technology Research Group, LSE Health, London School of Economics and Political Science, London, UK.

Disparities in access to oncology medicines in European Union (EU) member states can impact patient outcomes profoundly, with availability and timely access varying significantly across and within member states. This paper discusses the intersection of the new European Health Technology Assessment Regulation (HTAR), the provisions of the proposed pharmaceutical legislation and their potential impacts on access to oncology medicines across EU member states. The HTAR, seeking to standardise the clinical evaluation of new medicines, has the potential to streamline the evaluation process but also risks oversimplifying diverse national healthcare needs.

View Article and Find Full Text PDF

BACKGROUND For patients with end-stage renal disease, arteriovenous fistulas (AVFs) are often used for hemodialysis, but stenosis can impair their function. Traditional inpatient procedures to address AVF stenosis are effective but resource-intensive, prompting the need for alternative approaches like day surgery to optimize care and reduce costs. This study evaluated the feasibility of a day surgery model for AVF stenosis treatment in maintenance hemodialysis (MHD) patients, aiming to develop a cost-effective and high-quality care model.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!